In this section
CCG Approval Status:
The Cheshire and Merseyside Interim Area Prescribing Group recommends the prescribing of UPADACITINIB prolonged-release tablets (Rinvoq®▼), by specialists only, for active non-radiographic axial spondyloarthritis in accordance with NICE TA861.
NHS Cheshire and Merseyside APPROVED